A Combinatorial CRISPR-Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment. Xu F, Tong M, Tong CSW, Chan BKC, et al. Cancer Res 2021;81:6219-6232.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu F, Tong M, Tong CSW, Chan BKC, et al. A Combinatorial CRISPR-Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment. Cancer Res 2021;81:6219-6232.
PMID: 34666996